Sanjivani Paranteral Limited (BOM:531569)

Market Cap	2.10B -25.5%
Revenue (ttm)	686.66M -2.0%
Net Income	67.86M -16.2%
EPS	5.49 -17.6%
Shares Out	12.28M
PE Ratio	31.09
Forward PE	n/a
Dividend	0.50 (0.33%)
Ex-Dividend Date	n/a

Volume	48,520
Open	150.00
Previous Close	150.20
Day's Range	150.00 - 174.95
52-Week Range	126.00 - 268.80
Beta	-0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531569

Financial Performance

In fiscal year 2026, Sanjivani Paranteral's revenue was 686.66 million, a decrease of -2.04% compared to the previous year's 700.99 million. Earnings were 67.86 million, a decrease of -16.20%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 28, 2026

Data Sources Report a data error